Video

Opening the Door to Communication with Children About Genetic Mutations

Author(s):

At the 36th Annual Miami Breast Cancer Conference, Shannon Pulaski, founder of Proactive Genes, sat down with CURE® to discuss how parents can relate important health information, such as genetic mutations, to children of all ages.

Shannon Pulaski, author, patient advocate and founder of Proactive Genes, learned she was BRCA1-positive shortly after her mother was diagnosed with ovarian cancer. This genetic mutation meant that she would face a significantly increased chance of developing breast and/or ovarian cancer in her lifetime, for which she underwent prophylactic surgeries and treatments. Since the BRCA mutation could potentially be passed down to her kids, Pulaski was compelled as a mother to share her family health history with her children.

At the 36th Annual Miami Breast Cancer Conference, Pulaski shared her journey and offered advice to help parents open the door to conversations with their children about their own family health history. She also shared how Proactive Genes helps families start age-appropriate conversations about genetic mutations and heightened risk for cancer.

Related Videos
Dr. Michael Bogenschutz
Photo credit: Max Mumby/Indigo via Getty Images
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
Dr. Stephanie Alice Baker
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
Dr. Richard “Rick" Winneker